Tirzepatide with levocarnitine is another popular stack targeting fat metabolism
This interaction is widely documented but frequently overlooked in clinical practice
My hope is that sharing my experience helps reduce stigma and reminds people that needing support, whether lifestyle-based, medical, or both, is not a failure
GLP-1 can promote intracellular cholesterol outflow, reduce intracellular cholesterol content, and maintain intracellular cholesterol homeostasis through the ABCA1 pathway
The proportion of patients in the with prior cholecystectomy group who required medication with a dose greater than or equal to 150 mg/day to control hypoglycemic symptoms was significantly higher than in the without prior cholecystectomy group (69.6% vs 45.3%, respectively, p = 0.046, Table 3)